Lv1
20 积分 2024-12-27 加入
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
3个月前
已完结
Positioning therapies for the management of inflammatory bowel disease
3个月前
已完结
Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis
3个月前
已完结
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
3个月前
已完结
Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis
3个月前
已完结
Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double‐blind, placebo‐controlled, dose‐ranging study
3个月前
已完结
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
3个月前
已完结
Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease models
6个月前
已完结
Integrated isotyping and CDR identification of mouse monoclonal antibodies using multiplex RT-PCR
6个月前
已完结
TNF receptors: Structure-function relationships and therapeutic targeting strategies
6个月前
已完结
皖公网安备34019202002308
